Cargando…

Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer

Objectives: Chemotherapy and radiation therapy are the standard treatments for patients with small-cell lung cancer (SCLC). However, recent studies suggest that patients with limited stage (I-III) SCLC may benefit from surgical treatment. This study was performed to evaluate the survival outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Che, Keying, Shen, Hongchang, Qu, Xiao, Pang, Zhaofei, Jiang, Yuanzhu, Liu, Shaorui, Yang, Xudong, Du, Jiajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929087/ https://www.ncbi.nlm.nih.gov/pubmed/29721052 http://dx.doi.org/10.7150/jca.23583

Ejemplares similares

Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancer
por: Bie, Fenglong, et al.
Publicado: (2017)

Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma
por: Che, Keying, et al.
Publicado: (2017)

Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinoma
por: Li, Xiaowei, et al.
Publicado: (2017)

Evaluation of Preoperative Hematologic Markers as Prognostic Factors and Establishment of Novel Risk Stratification in Resected pN0 Non-Small-Cell Lung Cancer
por: Zhang, Tiehong, et al.
Publicado: (2014)

Prognostic model of AU-rich genes predicting the prognosis of lung adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2021)

Double-edged role of radiotherapy in patients with pulmonary large-cell neuroendocrine carcinoma
por: Jiang, Yuanzhu, et al.
Publicado: (2019)

The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort
por: Ding, Nan, et al.
Publicado: (2016)

Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis
por: Shen, Hongchang, et al.
Publicado: (2017)

Mining and validating the expression pattern and prognostic value of acetylcholine receptors in non-small cell lung cancer
por: Ma, Guoyuan, et al.
Publicado: (2019)

An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy
por: Wang, Ying, et al.
Publicado: (2018)

Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses
por: Han, Xiaoying, et al.
Publicado: (2019)

Effect of mu Agonists on Long-Term Survival and Recurrence in Nonsmall Cell Lung Cancer Patients
por: Wang, Kai, et al.
Publicado: (2015)

Impact of idiopathic pulmonary fibrosis on recurrence after surgical treatment for stage I–III non-small cell lung cancer
por: Song, Myung Jin, et al.
Publicado: (2020)

Survival analysis of surgical versus nonsurgical treatment in stage I to III small cell lung cancer in the last 20 years: A systematic review and meta‐analysis
por: Liang, Zhijian, et al.
Publicado: (2023)

Surgical perspective in neoadjuvant chemoimmunotherapy for stage II–III non‐small cell lung cancer
por: Hong, Tao, et al.
Publicado: (2021)

Adjuvant Chemotherapy Following Surgical Resection Improves Survival in Patients With Early Stage Small Cell Lung Cancer
por: Yao, Yuanshan, et al.
Publicado: (2019)

Development and validation of a prognostic model of resectable small-cell lung cancer: a large population-based cohort study and external validation
por: Wang, Yu, et al.
Publicado: (2020)

The Surgical Significance of Small Calibre Rifles—III
Publicado: (1895)

Regulation of response to radiotherapy by β-arrestin1 in Non-small cell lung cancer
por: Wang, Liguang, et al.
Publicado: (2019)

Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer
por: Li, Di, et al.
Publicado: (2021)

Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma
por: Wang, Guanghui, et al.
Publicado: (2018)

Non-surgical management of stage I lung cancer
por: Gore, Elizabeth M
Publicado: (2010)

Surgical management of stage III pediatric empyema thoracis
por: Singh, Aditya Pratap, et al.
Publicado: (2018)

Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer
por: Jiang, Wensheng, et al.
Publicado: (2018)

Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer
por: Wang, Siben, et al.
Publicado: (2020)

High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients
por: Ying, Hou-Qun, et al.
Publicado: (2021)

Antitumor Effect of Embryonic Stem Cells in a Non-Small Cell Lung Cancer Model: Antitumor Factors and Immune Responses
por: Dong, Wei, et al.
Publicado: (2013)

Distant Metastasis and Survival Outcomes after Computed Tomography-Guided Needle Biopsy in Resected Stage I-III Non-Small Cell Lung Cancer
por: Xi, Yuhui, et al.
Publicado: (2017)

Survival outcomes of surgical and non-surgical treatment in elderly patients with stage I pancreatic cancer: A population-based analysis
por: Nie, Duorui, et al.
Publicado: (2022)

Location of stage I–III non‐small cell lung cancer and survival rate: Systematic review and meta‐analysis
por: Lee, Hyun Woo, et al.
Publicado: (2018)

Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma
por: Lu, Di, et al.
Publicado: (2020)

30 Years of Experience in the Management of Stage III and IV Epithelial Ovarian Cancer: Impact of Surgical Strategies on Survival
por: Delga, Berenice, et al.
Publicado: (2020)

Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non–Small Cell Lung Cancer
por: Heiden, Brendan T., et al.
Publicado: (2021)

Surgical treatment of early-stage non-small-cell lung cancer
por: Van Schil, Paul E., et al.
Publicado: (2013)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017)

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
por: Shen, Hong, et al.
Publicado: (2016)

Surgical management and outcome analysis of stage III pediatric empyema thoracis
por: Menon, Prema, et al.
Publicado: (2010)

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer
por: Wang, Jun, et al.
Publicado: (2016)

Comparison of Surgical Outcomes and Survival between Octogenarians and Younger Patients after Pulmonary Resection for Stage I Lung Cancer
por: Hong, Seokbeom, et al.
Publicado: (2018)

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study
por: Kuroda, Hiroaki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_70cjd1ladpb0lvirv1ao2dn6f5